414 related articles for article (PubMed ID: 12749503)
1. Thalidomide: a review of approved and investigational uses.
Matthews SJ; McCoy C
Clin Ther; 2003 Feb; 25(2):342-95. PubMed ID: 12749503
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide: current and potential clinical applications.
Calabrese L; Fleischer AB
Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
[TBL] [Abstract][Full Text] [Related]
3. Dermatologic and nondermatologic uses of thalidomide.
Nasca MR; Micali G; Cheigh NH; West LE; West DP
Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
[TBL] [Abstract][Full Text] [Related]
4. Innovative uses of thalidomide.
Chen M; Doherty SD; Hsu S
Dermatol Clin; 2010 Jul; 28(3):577-86. PubMed ID: 20510766
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide for erythema nodosum leprosum and other applications.
Okafor MC
Pharmacotherapy; 2003 Apr; 23(4):481-93. PubMed ID: 12680478
[TBL] [Abstract][Full Text] [Related]
6. [New indications for thalidomide?].
Tuinmann G; Hegewisch-Becker S; Hossfeld DK
Dtsch Med Wochenschr; 2001 Oct; 126(42):1178-82. PubMed ID: 11607859
[No Abstract] [Full Text] [Related]
7. Thalidomide and its impact in dermatology.
Stirling DI
Semin Cutan Med Surg; 1998 Dec; 17(4):231-42. PubMed ID: 9859910
[TBL] [Abstract][Full Text] [Related]
8. Theoretical basis for the activity of thalidomide.
Meierhofer C; Dunzendorfer S; Wiedermann CJ
BioDrugs; 2001; 15(10):681-703. PubMed ID: 11604049
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide: an antineoplastic agent.
Amato RJ
Curr Oncol Rep; 2002 Jan; 4(1):56-62. PubMed ID: 11734114
[TBL] [Abstract][Full Text] [Related]
10. Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing.
Clark TE; Edom N; Larson J; Lindsey LJ
Drug Saf; 2001; 24(2):87-117. PubMed ID: 11235821
[TBL] [Abstract][Full Text] [Related]
11. [Thalidomide: new uses for an old drug].
Wu KL; Sonneveld P
Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
[TBL] [Abstract][Full Text] [Related]
12. A case series of 48 patients treated with thalidomide.
Doherty SD; Hsu S
J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide: dermatological indications, mechanisms of action and side-effects.
Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide: a re-look.
Grover JK; Vats V; Gopalakrishna R; Ramam M
Natl Med J India; 2000; 13(3):132-41. PubMed ID: 11558112
[TBL] [Abstract][Full Text] [Related]
15. Thalidomid: current role in the treatment of non-plasma cell malignancies.
Kumar S; Witzig TE; Rajkumar SV
J Clin Oncol; 2004 Jun; 22(12):2477-88. PubMed ID: 15197211
[TBL] [Abstract][Full Text] [Related]
16. [Thalidomide--a dreaded drug with new indications].
Waage A; Seidel C
Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2954-7. PubMed ID: 11715779
[TBL] [Abstract][Full Text] [Related]
17. Successful long-term thalidomide therapy for discoid lupus erythematosus-lichen planus overlap syndrome.
Zhang L; Au S; Aronson IK
Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526013
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide in multiple myeloma--clinical trials and aspects of drug metabolism and toxicity.
Breitkreutz I; Anderson KC
Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):973-85. PubMed ID: 18624684
[TBL] [Abstract][Full Text] [Related]
19. [Rediscovery of thalidomide. Successful treatment of discoid lupus erythematosus].
Kuhn A; Hefter H; Ruzicka T; Lehmann P
Hautarzt; 2001 Aug; 52(8):726-33. PubMed ID: 11544946
[TBL] [Abstract][Full Text] [Related]
20. Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.
Tseng S; Pak G; Washenik K; Pomeranz MK; Shupack JL
J Am Acad Dermatol; 1996 Dec; 35(6):969-79. PubMed ID: 8959957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]